Raymond James & Associates’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$170K Hold
2024
Q2
$299K Sell
2024
Q1
$242K Buy
2021
Q4
Sell
2021
Q3
$151K Buy
2021
Q2
Sell
2021
Q1
$742K Buy
2020
Q4
$202K Buy
2020
Q3
Sell
2020
Q2
$172K Buy
2020
Q1
$127K Sell
2019
Q4
$267K Sell
2019
Q3
$275K Sell
2019
Q2
$582K Buy
2019
Q1
$607K Buy
2018
Q4
$612K Sell
2018
Q3
$827K Sell
2018
Q2
$1.13M Buy
2018
Q1
$799K Buy